The Chinese Metabolic Management Centers.
- Published in:
- Journal of Diabetes, 2022, v. 14, n. 6, p. 362, doi. 10.1111/1753-0407.13290
- By:
- Publication type:
- Article
Works matching IS 17530393 AND DT 2022 AND VI 14 AND IP 6
Results: 7
1
2
Comprehensive risk profiles of family history and lifestyle and metabolic risk factors in relation to diabetes: A prospective cohort study.
- Published in:
- Journal of Diabetes, 2022, v. 14, n. 6, p. 414, doi. 10.1111/1753-0407.13289
- By:
- Publication type:
- Article
3
Effect of type 2 diabetes on A disintegrin and metalloprotease 10.
- Published in:
- Journal of Diabetes, 2022, v. 14, n. 6, p. 394, doi. 10.1111/1753-0407.13287
- By:
- Publication type:
- Article
4
Issue Information.
- Published in:
- Journal of Diabetes, 2022, v. 14, n. 6, p. 359, doi. 10.1111/1753-0407.13194
- Publication type:
- Article
5
Time‐limited diets and the gut microbiota in cardiometabolic disease.
- Published in:
- Journal of Diabetes, 2022, v. 14, n. 6, p. 377, doi. 10.1111/1753-0407.13288
- By:
- Publication type:
- Article
6
DUAL I China: Improved glycemic control with IDegLira versus its individual components in a randomized trial with Chinese participants with type 2 diabetes uncontrolled on oral antidiabetic drugs.
- Published in:
- Journal of Diabetes, 2022, v. 14, n. 6, p. 401, doi. 10.1111/1753-0407.13286
- By:
- Publication type:
- Article
7
Lipid variability and risk of microvascular complications in Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: A post hoc analysis.
- Published in:
- Journal of Diabetes, 2022, v. 14, n. 6, p. 365, doi. 10.1111/1753-0407.13273
- By:
- Publication type:
- Article